Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12116366 Azaindole rock inhibitors

Patent 12116366 was granted and assigned to Avicenna Biosciences, Inc. on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Avicenna Biosciences, Inc.

Current Assignee

‌

Avicenna Biosciences, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121163660

Patent Inventor Names

Thomas Maxwell Kaiser0

Date of Patent

October 15, 2024

Patent Application Number

186100410

Date Filed

March 19, 2024

Patent Citations

‌

US Patent 10717735 Solid forms of a compound for modulating kinases

‌

US Patent 6858638 Substituted indazoles, compositions containing them, method of production and use

Patent Primary Examiner

CPC Code

Patent abstract

This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12116366 Azaindole rock inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API